Show Summary Details
Page of

Suicide prevention trials 

Suicide prevention trials
Chapter:
Suicide prevention trials
Author(s):

Lakshmi Vijayakumar

, Melissa Pearson

, and Shuba Kumar

DOI:
10.1093/med/9780199680467.003.0014
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 24 November 2017

The majority of suicides occur in LAMIC. This chapter presents findings from two low-cost, feasible interventions aimed at reducing suicides. The Suicide Prevention Multisite Intervention Study (SUPRE-MISS) of WHO assessed the effectiveness of brief intervention and contact (BIC) as an intervention strategy in five countries. Another trial in South India examined the effectiveness of a central pesticide storage facility as a means of reducing pesticide suicides. Some challenges that such trials face are the large sample sizes required to detect a significant change, making them uneconomical and unfeasible. Dearth of reliable data on suicide and underreporting because of cultural norms and legal barriers compound the problem. Future research should incorporate effective surveillance for reliable data, address high-risk groups, and initiate large-scale intervention at the community level involving multiple collaborators. Multipronged strategies, addressing social inequities, and improving health services would be the way forward to reduce the burden of suicide.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.